Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 3,166,246 shares of EBS stock, worth $29.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,166,246
Previous 4,151,319
23.73%
Holding current value
$29.5 Million
Previous $10.5 Million
105.61%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding EBS
# of Institutions
149Shares Held
30.6MCall Options Held
137KPut Options Held
706K-
Black Rock Inc. New York, NY3.84MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.67MShares$34.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.24MShares$11.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny946KShares$8.83 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA897KShares$8.37 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $465M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...